Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention
- Paciaroni, Maurizio
- Agnelli, Giancarlo
- Giustozzi, Michela
- Caso, Valeria
- Toso, Elisabetta
- Angelini, Filippo
- Canavero, Isabella
- Micieli, Giuseppe
- Antonenko, Kateryna
- Rocco, Alessandro
- Diomedi, Marina
- Katsanos, Aristeidis H
- Shoamanesh, Ashkan
- Giannopoulos, Sotirios
- Ageno, Walter
- Pegoraro, Samuela
- Putaala, Jukka
- Strbian, Daniel
- Sallinen, Hanne
- Mac Grory, Brian C
- Furie, Karen L
- Stretz, Christoph
- Reznik, Michael E
- Alberti, Andrea
- Venti, Michele
- Mosconi, Maria Giulia
- Vedovati, Maria Cristina
- Franco, Laura
- Zepponi, Giorgia
- Romoli, Michele
- Zini, Andrea
- Brancaleoni, Laura
- Riva, Letizia
- Silvestrelli, Giorgio
- Ciccone, Alfonso
- Zedde, Maria Luisa
- Giorli, Elisa
- Kosmidou, Maria
- Ntais, Evangelos
- Palaiodimou, Lina
- Halvatsiotis, Panagiotis
- Tassinari, Tiziana
- Saia, Valentina
- Ornello, Raffaele
- Sacco, Simona
- Bandini, Fabio
- Mancuso, Michelangelo
- Orlandi, Giovanni
- Ferrari, Elena
- Pezzini, Alessandro
- Poli, Loris
- Cappellari, Manuel
- Forlivesi, Stefano
- Rigatelli, Alberto
- Yaghi, Shadi
- Scher, Erica
- Frontera, Jennifer A
- Masotti, Luca
- Grifoni, Elisa
- Caliandro, Pietro
- Zauli, Aurelia
- Reale, Giuseppe
- Marcheselli, Simona
- Gasparro, Antonio
- Terruso, Valeria
- Arnao, Valentina
- Aridon, Paolo
- Abdul-Rahim, Azmil H
- Dawson, Jesse
- Saggese, Carlo Emanuele
- Palmerini, Francesco
- Doronin, Boris
- Volodina, Vera
- Toni, Danilo
- Risitano, Angela
- Schirinzi, Erika
- Del Sette, Massimo
- Lochner, Piergiorgio
- Monaco, Serena
- Mannino, Marina
- Tassi, Rossana
- Guideri, Francesca
- Acampa, Maurizio
- Martini, Giuseppe
- Lotti, Enrico Maria
- Padroni, Marina
- Pantoni, Leonardo
- Rosa, Silvia
- Bertora, Pierluigi
- Ntaios, George
- Sagris, Dimitrios
- Baldi, Antonio
- D'Amore, Cataldo
- Mumoli, Nicola
- Porta, Cesare
- Denti, Licia
- Chiti, Alberto
- Corea, Francesco
- Acciarresi, Monica
- Flomin, Yuriy
- Popovic, Nemanja
- Tsivgoulis, Georgios
View in ORKG Publication date
March 2021
DOIAbstract
Clinical trials on stroke prevention in patients with atrial fibrillation have consistently shown clinical benefit from either warfarin or non-vitamin K antagonist oral anticoagulants (NOACs). NOAC-treated patients have consistently reported to be at lower risk for intracerebral hemorrhage (ICH) than warfarin-treated patients. The aims of this prospective, multicenter, multinational, unmatched, case-control study were (1) to investigate for risk factors that could predict ICH occurring in patients with atrial fibrillation during NOAC treatment and (2) to evaluate the role of CHA2DS2-VASc and HAS-BLED scores in the same setting